|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K 9/08 | (2013.01) | ||
| A61K 47/26 | (2006.01) | ||
| C07K 16/22 | (2013.01) | ||
| A61K 9/08 | (2006.01) | ||
| C07K 16/2887 | (2013.01) | ||
| C07K 16/22 | (2006.01) | ||
| A61K 47/26 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| A61K 39/39591 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 9/00 | (2018.01) | ||
| A61K 39/395 | (2013.01) |
| (11) | Number of the document | 3744345 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20181968.7 |
| Date of filing the European patent application | 2014-03-13 | |
| (97) | Date of publication of the European application | 2020-12-02 |
| (45) | Date of publication and mention of the grant of the patent | 2022-02-09 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201361780899 P | 2013-03-13 | US |
| (72) |
GOKARN, Yatin , US
ZARRAGA, Isidro, E. , US
ZARZAR, Jonathan , US
PATAPOFF, Thomas , US
WURTH, Christine , CH
|
| (73) |
F. Hoffmann-La Roche AG ,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | ANTIBODY FORMULATIONS |
| ANTIBODY FORMULATIONS |